Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective RPE Laser Treatment (SRT) for Various Macular Diseases

NCT00403884 is registered in ClinicalTrials.gov with University of Regensburg as lead sponsor.

NCT NCT00403884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00403884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective RPE Laser Treatment (SRT) for Various Macular Diseases
Lead sponsor
University of Regensburg
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2004
Completion date
August 31, 2010
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, central serous chorioretinopathy, diabetic maculopathy